Facts About Menopause / Boehringer Ingelheim Gmbh

Topic: Boehringer Ingelheim Gmbh

Longer time frame for clot-busting drug may help beat stroke

CBS 14 Sioux City (KMEG) | 6 hours ago

Extending the time window to treat stroke patients with the clot-dissolving drug tPA from 3 hours to up to 4.5 hours after the onset of stroke ...

CHMP Adopts Positive Opinion For TWYNSTA(R), Boehringer Ingelheim's New Single Pill Combination Hypertension Treatment

Medical News Today | 2 days ago

Boehringer Ingelheim announced that the European Committee for Medicinal Products for Human Use (CHMP) adopted a Positive Opinion for the approval...

Desire for 'female Viagra' excites passion

IOL, South Africa | 2 days ago

Ever since the explosion of the male impotence drug Viagra onto the global pharmaceutical market, drugmakers have yearned to find an equivalent for...

Study shows once-daily, extended-release formulation of nevirapine was not inferior to twice-daily Viramune in treatment-naïve HIV-1 infected patients

Drugs.com | 6 days ago

New data were presented today at the 18th International AIDS Conference from the VERxVE study that show an investigational, once-daily ...

FDA: 'Female Viagra' Falls Short in Boosting Women's Sex Drive

American Scientist | 41 days ago

from USA Today. . - The first pill designed to boost the female sex drive failed to make a significant impact on libido in two studies, federal...